Literature DB >> 17949349

Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells.

Shiro Miyata1, Tsuyoshi Fukushima, Kazuyo Kohama, Hiroyuki Tanaka, Hideo Takeshima, Hiroaki Kataoka.   

Abstract

Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a membrane-bound serine proteinase inhibitor having two extracellular Kunitz-type proteinase inhibitor domains (KD) namely KD-1 and KD-2. It efficiently inhibits hepatocyte growth factor activator, matriptase, hepsin, prostasin and trypsin. We have previously reported that the expression of HAI-1 suppresses the in vitro invasive capability of human glioblastoma cells. In this study we examined the role of each KD in the anti-invasive effect of HAI-1. Engineered over-expression of the mature membrane-form HAI-1 suppressed in vitro fibrin gel invasion of two human glioblastoma cell lines, U251 and YKG-1. The migratory activity on type IV collagen was also suppressed by the HAI-1 expression. These effects were not affected by the deletion of intracytoplasmic domain of HAI-1. A truncated secreted form of HAI-1 also suppressed in vitro invasion of the cells, indicating that the extracellular portion of HAI-1 was responsible for the anti-invasive effect. To determine the roles of each KD in the anti-invasive effect of HAI-1 in vitro, we constructed expression plasmids for HAI-1 with or without mutation at the P1 position of the reactive site of each KD. The results revealed that the proteinase inhibitor activity of N-terminal KD (KD-1) is responsible for the anti-invasion effect of HAI-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949349     DOI: 10.1111/j.1749-0774.2007.00035.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  32 in total

1.  Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer.

Authors:  Daniele Generali; Stephen B Fox; Alfredo Berruti; John W Moore; Maria Pia Brizzi; Nilay Patel; Giovanni Allevi; Simone Bonardi; Sergio Aguggini; Alessandra Bersiga; Leticia Campo; Luigi Dogliotti; Alberto Bottini; Adrian L Harris
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

2.  Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.

Authors:  Kimitoshi Denda; Takeshi Shimomura; Toshiya Kawaguchi; Keiji Miyazawa; Naomi Kitamura
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

3.  Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

Authors:  Daniel Kirchhofer; Mark Peek; Michael T Lipari; Karen Billeci; Bin Fan; Paul Moran
Journal:  FEBS Lett       Date:  2005-03-28       Impact factor: 4.124

4.  Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.

Authors:  R Szabo; A Molinolo; K List; T H Bugge
Journal:  Oncogene       Date:  2006-09-18       Impact factor: 9.867

5.  Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans.

Authors:  T Moriyama; H Kataoka; H Kawano; K Yokogami; S Nakano; T Goya; H Uchino; M Koono; S Wakisaka
Journal:  Cancer Lett       Date:  1998-02-27       Impact factor: 8.679

6.  Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Virote Sriuranpong; Vivien Redeye; Tricia Murdock; Beth Burke; Boye S Nielsen; J Silvio Gutkind; Thomas H Bugge
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

7.  Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin.

Authors:  Bin Fan; Thomas D Wu; Wei Li; Daniel Kirchhofer
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

8.  Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.

Authors:  Shunro Uchinokura; Shiro Miyata; Tsuyoshi Fukushima; Hiroshi Itoh; Shinichi Nakano; Shinichiro Wakisaka; Hiroaki Kataoka
Journal:  Int J Cancer       Date:  2006-02-01       Impact factor: 7.396

9.  Hepsin promotes prostate cancer progression and metastasis.

Authors:  Olga Klezovitch; John Chevillet; Janni Mirosevich; Richard L Roberts; Robert J Matusik; Valeri Vasioukhin
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

10.  Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer.

Authors:  Hiroshi Kobayashi; Tatsuo Yagyu; Kiyokazu Inagaki; Toshiharu Kondo; Mika Suzuki; Naohiro Kanayama; Toshihiko Terao
Journal:  Cancer       Date:  2004-02-15       Impact factor: 6.860

View more
  6 in total

1.  Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways.

Authors:  Cláudia Alessandra Andrade de Paula; Vivien Jane Coulson-Thomas; Joana Gasperazzo Ferreira; Paloma Korehisa Maza; Erika Suzuki; Adriana Miti Nakahata; Helena Bonciani Nader; Misako Uemura Sampaio; Maria Luiza V Oliva
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

2.  Proteolytic cleavage of human acid-sensing ion channel 1 by the serine protease matriptase.

Authors:  Edlira B Clark; Biljana Jovov; Arun K Rooj; Catherine M Fuller; Dale J Benos
Journal:  J Biol Chem       Date:  2010-07-02       Impact factor: 5.157

3.  Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells.

Authors:  Hiroyuki Tanaka; Tsuyoshi Fukushima; Kenji Yorita; Makiko Kawaguchi; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2009-02       Impact factor: 4.174

4.  The type II transmembrane serine protease matriptase cleaves the amyloid precursor protein and reduces its processing to β-amyloid peptide.

Authors:  Erwan Lanchec; Antoine Désilets; François Béliveau; Anthony Flamier; Shaimaa Mahmoud; Gilbert Bernier; Denis Gris; Richard Leduc; Christine Lavoie
Journal:  J Biol Chem       Date:  2017-10-20       Impact factor: 5.157

5.  Molecular and physiological mechanisms of membrane receptor systems functioning.

Authors:  E S Severin; M V Savvateeva
Journal:  Acta Naturae       Date:  2011-01       Impact factor: 1.845

6.  Hepatocyte growth factor activator inhibitor-1 is induced by bone morphogenetic proteins and regulates proliferation and cell fate of neural progenitor cells.

Authors:  Raili Koivuniemi; Johanna Mäkelä; Marie-Estelle Hokkanen; Céline Bruelle; Tho Huu Ho; Roxana Ola; Laura Korhonen; Jim Schröder; Hiroaki Kataoka; Dan Lindholm
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.